Research graph
References from Primary Ciliary Dyskinesia: Use of Airway Clearance in the NICU and Beyond. Local targets link to admitted publications; unresolved targets remain external evidence.
European Respiratory Society and American Thoracic Society guidelines for the diagnosis of primary ciliary dyskinesia
10.1183/13993003.00745-2025 · 2025 · External reference
Estimates of primary ciliary dyskinesia prevalence: a scoping review
10.1183/23120541.00989-2023 · 2024 · External reference
Respiratory distress in the newborn with primary ciliary dyskinesia
2021 · External reference
Diagnosing primary ciliary dyskinesia: an international patient perspective
10.1183/13993003.02018-2015 · 2016 · External reference
Primary ciliary dyskinesia
10.1542/peds.2023-063064 · 2024 · External reference
Recognizing clinical features of primary ciliary dyskinesia in the perinatal period
10.1038/s41372-024-02068-1 · 2024 · External reference
Primary ciliary dyskinesia
10.1055/s-0035-1546748 · 2015 · External reference
Primary ciliary dyskinesia
10.1016/j.chpulm.2023.100004 · 2023 · External reference
The effect of intrapulmonary percussive ventilation in pediatric patients: a systematic review
10.1002/ppul.24135 · 2018 · External reference
A comparison of intrapulmonary percussive ventilation and conventional chest physiotherapy for the treatment of atelectasis in the pediatric patient
10.1177/002013240204701006 · 2002 · External reference
Efficacy of intrapulmonary percussive ventilation in a newborn with primary ciliary dyskinesia
10.1002/ppul.70995 · 2025 · External reference
Beyond the present: current and future perspectives on the role of infections in pediatric PCD
10.3389/fped.2025.1564156 · 2025 · External reference
Reducing exacerbations in children and adults with primary ciliary dyskinesia using erdosteine and/or azithromycin therapy (REPEAT trial): study protocol for a multicentre, double-blind, double-dummy, 2×2 partial factorial, randomised controlled trial
10.1136/bmjresp-2022-001236 · 2022 · External reference
Efficacy and safety of azithromycin maintenance therapy in primary ciliary dyskinesia (BESTCILIA): a multicentre, double-blind, randomised, placebo-controlled phase 3 trial
10.1016/s2213-2600(20)30058-8 · 2020 · External reference
